Speaker illustration

Professor Otavio Berwanger

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

Professor Otavio Berwanger (MD; PhD) is a cardiologist and clinical trialist who has been working as Chair of the Steering Committee of large-scale international randomized clinical trials He coordinates a network of several Cardiovascular Research Sites in various countries. He is currently the Executive Director of the George Institute for Global Health UK, and Chair in Clinical Trials at Imperial College London-UK. He was the main presenter of several clinical trials in late-breaking clinical trial sessions at the American College of Cardiology Scientific Sessions, American Heart Association Scientific Sessions and European Congress of Cardiology-ESC. He has published manuscripts in major medical journals such as New England Journal of Medicine, Lancet, JAMA, BMJ, Annals of Internal Medicine, Circulation, JACC and the European Heart Journal.

Hypertension management of patient with cardiometabolic comorbidities: moving from a disease-centred to a patient-centred approach

Event: ESC Congress 2023

Topic: Comorbidities

Session type: Satellite Symposium

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb